These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations. Segars JH; Parrott EC; Nagel JD; Guo XC; Gao X; Birnbaum LS; Pinn VW; Dixon D Hum Reprod Update; 2014; 20(3):309-33. PubMed ID: 24401287 [TBL] [Abstract][Full Text] [Related]
26. Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype. Saini P; Holmes AG; Wei JJ; Parker JB; Chakravarti D F S Sci; 2024 Nov; 5(4):352-368. PubMed ID: 39074663 [TBL] [Abstract][Full Text] [Related]
27. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Moravek MB; Bulun SE Curr Opin Obstet Gynecol; 2015 Aug; 27(4):276-83. PubMed ID: 26107781 [TBL] [Abstract][Full Text] [Related]
28. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1. Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448 [TBL] [Abstract][Full Text] [Related]
29. From 2646 to 15: differentially regulated microRNAs between progenitors from normal myometrium and leiomyoma. Lazzarini R; Caffarini M; Delli Carpini G; Ciavattini A; Di Primio R; Orciani M Am J Obstet Gynecol; 2020 Jun; 222(6):596.e1-596.e9. PubMed ID: 31874141 [TBL] [Abstract][Full Text] [Related]
30. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas. Sato S; Maekawa R; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Sugino N J Reprod Dev; 2014 Mar; 60(1):47-54. PubMed ID: 24291816 [TBL] [Abstract][Full Text] [Related]
31. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276 [TBL] [Abstract][Full Text] [Related]
32. Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas. Conconi D; Redaelli S; Lissoni AA; Cilibrasi C; Perego P; Gautiero E; Sala E; Paderno M; Dalprà L; Landoni F; Lavitrano M; Roversi G; Bentivegna A Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557274 [TBL] [Abstract][Full Text] [Related]
33. Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health. Xavier MJ; Roman SD; Aitken RJ; Nixon B Hum Reprod Update; 2019 Sep; 25(5):518-540. PubMed ID: 31374565 [TBL] [Abstract][Full Text] [Related]
34. Aberrant DNA methylation status in human uterine leiomyoma. Yamagata Y; Maekawa R; Asada H; Taketani T; Tamura I; Tamura H; Ogane J; Hattori N; Shiota K; Sugino N Mol Hum Reprod; 2009 Apr; 15(4):259-67. PubMed ID: 19218588 [TBL] [Abstract][Full Text] [Related]
35. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Mehine M; Kaasinen E; Heinonen HR; Mäkinen N; Kämpjärvi K; Sarvilinna N; Aavikko M; Vähärautio A; Pasanen A; Bützow R; Heikinheimo O; Sjöberg J; Pitkänen E; Vahteristo P; Aaltonen LA Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1315-20. PubMed ID: 26787895 [TBL] [Abstract][Full Text] [Related]
36. Racial differences in transcriptomics and reactive oxygen species burden in myometrium and leiomyoma. Li Y; McNally RP; Feng Y; Kim JJ; Wei JJ Hum Reprod; 2023 Apr; 38(4):609-620. PubMed ID: 36749068 [TBL] [Abstract][Full Text] [Related]
37. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids. Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572 [TBL] [Abstract][Full Text] [Related]
38. 5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas. Carbajo-García MC; Corachán A; Segura-Benitez M; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H Reprod Biol Endocrinol; 2021 Jul; 19(1):106. PubMed ID: 34233687 [TBL] [Abstract][Full Text] [Related]
39. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway. Varghese BV; Koohestani F; McWilliams M; Colvin A; Gunewardena S; Kinsey WH; Nowak RA; Nothnick WB; Chennathukuzhi VM Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2187-92. PubMed ID: 23284171 [TBL] [Abstract][Full Text] [Related]
40. Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy. Äyräväinen A; Pasanen A; Ahvenainen T; Heikkinen T; Pakarinen P; Härkki P; Vahteristo P Hum Reprod; 2020 Oct; 35(10):2237-2244. PubMed ID: 32829387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]